• Sonuç bulunamadı

藥學科技上課心得:卓韋利

N/A
N/A
Protected

Academic year: 2021

Share "藥學科技上課心得:卓韋利"

Copied!
5
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

B303098139 卓韋利

 Scifinder

1. 搜尋過程及結果 想了解最近學到的Finasteride(口服生髮藥)的作用機轉 於是輸入關鍵字Finasteride 得到3954 的完全符合的結果及 4070 個含此概念的結果,資料量太龐大,且大多 是我不需要的,於是將關鍵字改成 Finasteride mechanism

(2)

得到3 個完全符合的結果以及 97 個含此概念的結果,其中一個完全符合的結果 中含有我要的資料

使用心得

: 是個很容易上手的網站,所含有的資料量非常龐大,範圍也非常廣, 但是只要善用關鍵字,很容易在此網站中迅速找到平常搜尋引擎上找不到的精確 專業資料,且不需要完全符合,網站也會自動列出有相關的搜尋結果,這點非常 方便,但是美中不足的是,由於本校只有兩個可同時登入的名額,減低不少了此 軟體的實用性,而因為此網站是用英文介面,所以在不知道專有名詞時,必須先 去翻書找到正確的學名翻譯,才能再利用此網站找到需要的資料。從此網站也可 看出資料的全球流通性,掌握資訊的人做事總能先人一步,整體來說是個很棒的 學經驗。

(3)

 Thomson innovation

1. 搜尋過程與結果 想 搜 尋 葛 蘭 素 史 克 藥 廠(GlaxoSmithKline, 簡 稱 為 GSK)所 擁 有 的 醫 療 器 材 專 利 , 選 擇 Assignee/Applicant 後 輸 入 GSK 獲得10 筆資料,但其中很多名稱都是重複的 所以再加入關鍵字DEVICE 後,得到一筆結果資料

(4)

其內容為大致為

DWPI Title

Device for monitoring patient usage of medicament inhaler, has optical dose counter that determines when dose of medicament has been dispensed by transmitting optical signals via medicament inhaler

Original Title

Medicament Inhalers Abstract

This invention relates to improvements in or relating to medicament inhalers. In particular, the invention relates to a device for releasable attachment to a medicament inhaler, which monitors patient usage of the medicament inhaler. The invention may be particularly suitable for use with medicament inhalers used for the treatment of respiratory diseases. First Claim

1. A device for monitoring patient usage of a medicament inhaler, said medicament inhaler being adapted to deliver doses of medicament, and wherein said medicament inhaler includes parts which move during the dispensing of a dose of medicament,

• wherein said device includes:

• a) a housing, said housing being releasably attachable to said medicament inhaler,

• b) an optical dose counter associated with said housing, said optical dose counter being adapted to determine when a dose of medicament has been dispensed by transmitting optical signals through the medicament inhaler,

• c) an electronic control module associated with said housing, said electronic control module including, or being in communication with, said optical dose counter, d) said electronic control module being adapted to monitor and/or store data relating to patient usage of said medicament inhaler,

o the arrangement and construction being such that said device is attachable

(5)

modifications being required to be made to said medicament inhaler.

Assignee / Applicant Standardized: NEXUS6 LTD

Original: Nexus6 Limited, Auckland, NZ Inventor

SUTHERLAND GARTH C GORMACK MICHAEL J BEZMATERNYKH PAVEL Publication Number / Date

/ 2010-08-05

US20100192948A1

Application Number / Date

/ 2009-03-06

US2009381145A

Priority Number / Date NZ574666A / 2009-02-05 US2009381145A / 2009-03-06

使用心得:

想找和台灣醫院比較有合作往來的大藥廠的各種專利,於是選上最近 才跟台大醫院臨床中心簽約的葛 蘭 素 史 克 藥 廠 , I n n o v a t i o n 感覺沒有像 scifinder 那樣容易上手,而且或許是因為自己對專利領域不太熟悉,使用起來沒 有 scifinder 那種驚艷的感覺,起初搜尋關鍵字時很容易搜尋不到任何資料,所以 換了很多關鍵字多次嘗試,本身應該要更清楚各種專利方面各種專業用語才會更 適合這套軟體,而配合多個關鍵字時似乎很容易忽略其他可能的相關資料,例 如,我一開始搜尋 GSK,得到的 10 筆資料中,其實有不只一個跟醫療器材相關 的專利,但加入關鍵字 DEVICE 後,卻剩下一個搜尋結果,雖然此搜尋結果符 合我要的,但卻遺漏了其他幾項我也需要的專利資料

Referanslar

Benzer Belgeler

高膽固醇飲食添加紅麴粉末 (Monascus Extract) 對倉鼠體內脂質代謝與血漿總抗氧化 能力之影響 謝孟志 1 、黃士懿 2 、錢 信 3 、楊惠婷 4

[r]

Secondary data analysis was carried out on the 712 subjects who were at least 50 years old and had reported having hypertension in order to assess the effects of demographic,

鈣離子阻斷器 脈優錠 (NORVASC) 達爾能持續性膠囊 (Diltelan) 合必爽錠 (Herbesser) 培爾吉平糖衣錠 (Perdipine) 壓達能軟膠囊

Efficacy analysis was the changes in blood pressure and number of patients meeting their goal blood pressure before and after therapeutic interchange.. Safety analysis was to

Efficacy analysis was the cha nges in blood pressure and number of patients meeting their goal blood pressure before and after therapeutic interchange.. Safe ty analysis was to

高血壓病患牙科就醫應注意的事項 返回 醫療衛教 發表醫師 發佈日期 2010/02 /18

symptoms before or after diagnosis were more likely to adhere to self management activities than those who were uncertain; (3) the findings of confirmatory factor analysis